Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund - Medical Sub-Fund

+ Add to Watchlist

CARMEII:LX

1,067.11 NOK 8.94 0.84%

As of 00:59:30 ET on 01/28/2015.

Snapshot for Carnegie Fund - Medical Sub-Fund (CARMEII)

Year To Date: +7.03% 3-Month: +26.48% 3-Year: +38.76% 52-Week Range: 639.25 - 1,058.17
1-Month: +8.46% 1-Year: +58.21% 5-Year: +24.47% Beta vs LUXXX: 0.57

Mutual Fund Chart for CARMEII

No chart data available.
  • CARMEII:LX 1,067.11
  • 1M
  • 1Y
Interactive CARMEII Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARMEII

Carnegie Fund - Medical Sub-Fund is an FCP incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests globally in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors.

Inception Date: 12-18-2000 Telephone: 352-40-40-30-1
Managers: ANGELICA FATOUROS
Web Site: www.carnegieam.com

Fundamentals for CARMEII

NAV (on 2015-01-28) 1,067.11
Assets (M) (on 2014-12-31) 617.02
Fund Leveraged N
Minimum Investment 1,000,000.00
Minimum Subsequent Investment -

Dividends for CARMEII

No dividends reported

Fees & Expenses for CARMEII

Front Load 3.00
Back Load 0.50
Current Mgmt Fee 0.70
Redemption Fee 0.50
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CARMEII

Filing Date: 12/31/2014
Name Position Value % of Total
Gilead Sciences Inc 529,672 42,255,774 6.848%
Johnson & Johnson 363,186 31,773,157 5.149%
Carnegie Fund V - The Carnegie 108,460 31,590,098 5.120%
Novartis AG 410,862 31,556,142 5.114%
Amgen Inc 228,638 30,603,275 4.960%
Roche Holding AG 128,741 28,898,200 4.684%
UnitedHealth Group Inc 329,158 28,111,902 4.556%
Pfizer Inc 1,036,315 26,957,357 4.369%
Celgene Corp 283,838 26,772,707 4.339%
Biogen Idec Inc 82,892 23,629,110 3.830%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil